Surrogate Endpoints: A Valuable Tool for Accelerating the Development of Cancer Therapies

Surrogate Endpoints: A Valuable Tool for Accelerating the Development of Cancer Therapies

By Harry Lander on November 12, 2025

Discover how surrogate endpoints accelerate cancer treatment development by offering early, reliable insights into therapy effectiveness.
Cancer Recurrence: Detecting Relapse Before It Strikes

Cancer Recurrence: Detecting Relapse Before It Strikes

By Harry Lander on November 7, 2025

Explore how liquid biopsy is transforming early detection of cancer recurrence through precise, noninvasive monitoring.
The Evolution of Cancer Treatments: From Surgery to Immunotherapy

The Evolution of Cancer Treatments: From Surgery to Immunotherapy

By Harry Lander on October 30, 2025

Discover the journey of cancer treatment from ancient surgical methods to modern immunotherapy, highlighting key breakthroughs that revolutionized patient care.
Canary Oncoceutics Revolutionizing Cancer Diagnostics

Canary Oncoceutics Revolutionizing Cancer Diagnostics

By Harry Lander on October 21, 2025

Discover how Canary Oncoceutics is transforming cancer diagnostics with precise, AI-powered genomic testing.
CanaryScan™ Prostate: Non-Invasive Early Cancer Detection

CanaryScan™ Prostate: Non-Invasive Early Cancer Detection

By Harry Lander on October 1, 2025

Discover CanaryScan Prostate, a non-invasive urine-based test powered by AI, offering superior accuracy, sensitivity, and accessibility in early prostate cancer detection compared to traditional methods.
Canary Acuity™ and Canary Pulse™

Canary Acuity™ and Canary Pulse™

By Harry Lander on September 25, 2025

Explore how Canary Acuity and Canary Pulse are revolutionizing cancer diagnostics with next-gen genomic profiling and liquid biopsy, delivering personalized treatment insights and better outcomes.